Transfusionsmedizin,
Journal Year:
2024,
Volume and Issue:
14(04), P. 190 - 199
Published: Nov. 1, 2024
Zusammenfassung
Kleine
(small)
extrazelluläre
Vesikel
(sEVs)
sind
biologische
Nanopartikel
mit
Größen
von
unter
200
nm,
die
praktisch
allen
Zellen
freigesetzt
und
in
Körperflüssigkeiten
nachgewiesen
werden
können.
Ihre
Zusammensetzung
ist
zellspezifisch,
ein
Teil
der
sEVs
kann
komplexe
Informationen
sendenden
zu
spezifisch
ausgewählten
Zielzellen
übertragen.
Abhängig
ihrem
Ursprung
können
physiologische
pathophysiologische
Prozesse
steuern.
sEVs,
mesenchymalen
Stamm-/Stromazellen
(MSCs)
werden,
vermitteln
beispielsweise
therapeutische
Aktivitäten
bei
einer
Vielzahl
verschiedener
Krankheiten,
deren
Symptomatik
Entzündungsprozessen
geprägt
ist.
Obwohl
ihre
konkreten
Wirkmechanismen
(mode
of
action;
MoA)
sowie
Wirkorte
(side
SoA)
noch
nicht
ausreichend
untersucht
wurden,
scheint
es,
dass
MSC-sEVs
multimodal
wirken.
Es
gibt
Hinweise
darauf,
MSC-sEV-Präparate
als
ihrer
therapeutischen
pro-inflammatorische
regulatorische/tolerogene
Immunantworten
umwandeln,
angiogene
pro-regenerative
fördern
anti-apoptotisch
energieerhaltend
Hier
beschreiben
wir
Historie,
zur
Entdeckung
geführt
hat,
einige
Anwendungsfelder
Herausforderungen
effektiven
Translation
Klinik.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(6), P. 6709 - 6742
Published: Feb. 5, 2024
Information
exchange
is
essential
for
the
brain,
where
it
communicates
physiological
and
pathological
signals
to
periphery
vice
versa.
Extracellular
vesicles
(EVs)
are
a
heterogeneous
group
of
membrane-bound
cellular
informants
actively
transferring
informative
calls
from
brain
via
lipids,
proteins,
nucleic
acid
cargos.
In
recent
years,
EVs
have
also
been
widely
used
understand
function,
given
their
"cell-like"
properties.
On
one
hand,
presence
neuron
astrocyte-derived
in
biological
fluids
exploited
as
biomarkers
mechanisms
progression
multiple
neurological
disorders;
on
other,
designing
targeted
therapies
due
potential
cross
blood-brain-barrier
(BBB).
Despite
expanding
literature
context
central
nervous
system
(CNS)
physiology
related
disorders,
comprehensive
compilation
existing
knowledge
still
needs
be
made
available.
current
review,
we
provide
detailed
insight
into
multifaceted
role
brain-derived
extracellular
(BDEVs)
intricate
regulation
physiology.
Our
focus
extends
significance
these
spectrum
including
tumors,
neurodegenerative
conditions,
neuropsychiatric
diseases,
autoimmune
others.
Throughout
parallels
drawn
using
various
evaluating
utility
early
detection
monitoring.
Additionally,
discuss
promising
prospects
utilizing
therapy
while
acknowledging
limitations
challenges
associated
with
applications
clinical
scenarios.
A
foundational
comprehension
state-of-the-art
EV
research
informing
design
future
studies.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 29, 2024
Abstract
The
field
of
neuropsychiatry
is
considered
a
middle
ground
between
neurological
and
psychiatric
disorders,
thereby
bridging
the
conventional
boundaries
matter
mind,
consciousness,
function.
Neuropsychiatry
aims
to
evaluate
treat
cognitive,
behavioral,
emotional
disorders
in
individuals
with
conditions.
However,
pathophysiology
these
not
yet
fully
understood,
objective
biological
indicators
for
conditions
are
currently
lacking.
Treatment
options
also
limited
due
blood–brain
barrier,
which
results
poor
treatment
effects.
Additionally,
many
drugs,
particularly
antipsychotic
have
adverse
reactions,
make
them
difficult
tolerate
patients.
As
result,
patients
often
abandon
owing
reactions.
Since
discovery
exosomes
1983,
they
been
extensively
studied
various
diseases
their
potential
as
nanocellulators
information
exchange
cells.
Because
can
freely
travel
center
periphery,
brain-derived
reflect
state
brain,
has
considerable
advantages
diagnosis
treatment.
In
addition,
administration
engineered
improve
therapeutic
efficacy,
allow
lesion
targeting,
ensure
drug
stability,
prevent
systemic
Therefore,
this
article
reviews
source
function
exosomes,
relationship
pathological
mechanism
neuropsychiatric
application
disorders.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 1, 2024
Exosomes
play
a
crucial
role
in
various
biological
processes,
such
as
human
development,
immune
responses,
and
disease
occurrence.
The
membrane
proteins
on
exosomes
are
pivotal
factors
for
their
functionality.
Currently,
numerous
have
been
identified
exosome
membranes,
participating
intercellular
communication,
mediating
target
cell
recognition,
regulating
processes.
Furthermore,
from
derived
cancer
cells
can
serve
relevant
biomarkers
early
diagnosis.
This
article
provides
comprehensive
review
of
the
composition
diverse
functions
organism's
Through
in-depth
exploration
proteins,
it
is
expected
to
offer
essential
foundations
future
development
novel
biomedical
diagnostics
therapies.
The Journal of Physiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
Abstract
Ischaemic
stroke
is
a
leading
cause
of
death
and
disability.
Circulating
extracellular
vesicles
(EVs)
post‐stroke
may
help
brain
endothelial
cells
(BECs)
counter
ischaemic
injury.
However
data
on
how
EVs
from
patients,
considering
injury
severity,
affect
these
are
limited.
The
aims
were
to
characterize
the
inflammatory
angiogenic
components
circulating
in
acute
investigate
whether
differentially
influence
proangiogenic
properties
blood–brain
barrier
(BBB)
integrity
human
BECs.
Eighteen
patients
(acute
phase:
24–48
h)
nine
controls
matched
by
age,
sex,
blood
pressure
studied.
Stroke
severity
was
classified
as
severe
(
n
=
9)
or
mild
9).
Plasma
analysed
for
size,
concentration,
protein
markers
(CD63,
Alix,
CD81,
TSG101,
HSP70),
well
proinflammatory
proteins.
EV
uptake,
cell
viability,
capacity,
electrical
resistance
[TEER
(transendothelial
resistance)],
dextran‐70
kD
permeability
assessed
using
microvascular
(hCMEC/D3).
had
lower
concentrations
than
p
0.075),
with
mild‐stroke
having
smallest
EVs.
Stroke‐derived
higher
levels
interleukin
6
(IL‐6),
tumour
necrosis
factor
α
(TNF‐α),
nitrotyrosine,
vascular
growth
(VEGF)
but
placental
(PLGF)
compared
controls.
IL‐6
strokes
0.0025),
VEGF
0.048).
severe‐stroke
cases
enhanced
capacity
minimally
disrupted
BBB.
influences
number,
composition.
promote
BBB
restoration
cerebral
angiogenesis,
suggesting
their
role
intercellular
communication
homeostasis
tissue.
image
Key
points
one
causes
worldwide.
After
an
several
physiological
processes
triggered
recover
injured
Increasing
evidence
has
suggested
that
present
bloodstream
could
play
recovery,
specific
impact,
especially
concerning
unclear.
This
study
demonstrates
plasma‐derived
first‐ever
have
distinctive
characteristics
effects
over
angiogenesis
integrity.
Our
proposes
carry
protective
factors
initiate
recovery
after
episodes.
These
findings
underscore
potential
effectors
biomarkers
stroke.
Alzheimer s & Dementia,
Journal Year:
2025,
Volume and Issue:
21(3)
Published: March 1, 2025
Alzheimer's
disease
(AD)
is
the
leading
cause
of
dementia,
affecting
around
50
million
individuals
worldwide.
Brain-derived
extracellular
vesicles
(EVs)
can
cross
blood-brain
barrier
carrying
neuron-specific
molecules,
such
as
microRNAs
(miRNAs),
which
have
potential
biomarkers
neurodegeneration.
We
explored
association
between
neuronal-derived
EV
miRNAs
from
serum
and
AD
clinical
status
by
performing
a
transcriptome-wide
study
involving
46
participants
with
AD,
14
preclinical
60
neurologically
healthy
controls.
identified
associated
risk,
more
pronounced
transcriptional
alterations
in
compared
to
individuals.
Functional
analysis
revealed
enrichment
miRNA-target
genes
neurodegenerative
pathways,
highlighting
synuclein
alpha
(SNCA),
cytochrome
c,
somatic
(CYCS),
microtubule
protein
tau
(MAPT)
key
targets.
Our
results
highlight
role
EVs
neurodegeneration
suggest
avenues
for
further
research
into
brain-derived
biomarkers.
Neuronal-derived
(NDEVs)
carry
brain
tested
NDEV
(miRNAs)
(AD).
Fourteen
were
AD.
Preclinical
displayed
changes
than
enriched
pathways
Journal of Cerebral Blood Flow & Metabolism,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 12, 2025
Extracellular
vesicles
(EVs)
convey
complex
signals
between
cells
that
can
be
used
to
promote
neuronal
plasticity
and
neurological
recovery
in
brain
disease
models.
These
EV
are
multimodal
context-dependent,
making
them
unique
therapeutic
principles.
This
review
analyzes
how
EVs
released
from
various
cell
sources
control
metabolic
function,
survival
plasticity.
Preferential
sites
of
communication
the
interfaces
pre-
postsynaptic
neurons
at
synapses,
astrocytes
plasma
membranes
or
tripartite
oligodendrocytes
axons,
microglial
cells/macrophages
neurons,
cerebral
microvascular
neurons.
At
each
these
interfaces,
support
mitochondrial
function
metabolism
under
physiological
conditions
orchestrate
response
injury.
In
injured
brain,
promotion
by
is
tightly
linked
with
actions
on
metabolism,
oxidative
stress
immune
responses.
Via
stabilization
balance,
responses
activated
functional
induced.
As
such,
lay
ground
for
Journal of Cerebral Blood Flow & Metabolism,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
Demyelination
is
a
common
feature
of
neuroinflammatory
and
degenerative
diseases
the
central
nervous
system
(CNS),
such
as
multiple
sclerosis
(MS).
It
often
linked
to
disruptions
in
intercellular
communication,
bioenergetics
metabolic
balance
accompanied
by
mitochondrial
dysfunction
cells
oligodendrocytes,
neurons,
astrocytes,
microglia.
Although
current
MS
treatments
focus
on
immunomodulation,
they
fail
stop
or
reverse
demyelination’s
progression.
Recent
advancements
highlight
exchange
promising
therapeutic
target,
with
potential
restore
homeostasis,
enhance
promote
myelin
repair.
With
this
review
we
will
provide
insights
into
CNS
decoupling,
focusing
role
demyelinating
conditions.
We
then
discuss
emerging
cell-free
biotherapies
exploring
transferring
mitochondria
via
biogenic
carriers
like
extracellular
vesicles
(EVs)
synthetic
liposomes,
aimed
at
enhancing
function
support
for
Lastly,
address
key
challenges
clinical
application
these
strategies
future
directions
optimize
biotherapies.
The
field
hold
promise
restoring
repair,
potentially
transforming
landscape
diseases.
Journal of Dental Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 25, 2025
Extracellular
vesicles
(EVs)
are
lipid-enclosed
particles
released
from
cells,
containing
lipids,
DNA,
RNA,
metabolites,
and
cytosolic
cell
surface
proteins.
EVs
support
intercellular
communication
orchestrate
organogenesis
by
transferring
bioactive
molecules
in
between
cells.
Mesenchymal
stem
cells
known
to
produce
EVs,
which
exhibit
immunomodulatory
regenerative
capabilities
many
target
organs,
including
the
salivary
glands
(SGs).
Since
cell-based
therapies
still
pose
challenges
(e.g.,
donor
variability,
limited
hemocompatibility,
safety),
specific
may
constitute
a
therapeutic
alternative
for
SG
diseases.
New
EV
guidelines
(MISEV2023)
have
recently
been
updated
reported
our
consortium
consolidate
principles
of
biology
expand
boundaries
toward
innovative
therapies.
These
provide
valuable
guidance
researchers
consistently
assess
effectiveness
mesenchymal
cell–derived
cargo
cues,
such
as
microRNA,
proteins,
other
molecules,
This
review
provides
narrative
synthesis
preclinical
studies
on
highlighting
mechanisms
their
potential
applications
diseases,
radiotherapy-induced
hypofunction
Sjögren’s
syndrome,
well
inflammatory
aging-related
conditions.
Additionally,
we
highlight
key
areas
MISEV2023
that
will
future
EV-based
research.
adhered
PRESS
(Peer
Review
Electronic
Search
Strategies)
utilized
established
databases,
Medline/PubMed,
Embase,
Web
Science,
Scopus,
alongside
machine
learning
tools
sorting
most
impactful